Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Sunday, November 29, 2020

Immunogenicity and safety of the quadrivalent human papillomavirus vaccine

alkiviadis.1961 shared this article with you from Inoreader
Via Vaccine

fbworm.png

CONCLUSION: Antibody responses induced by the 3-dose qHPV vaccination regimen in Chinese girls aged 9-19 years were non-inferior to those in Chinese young women aged 20-26 years. The vaccine was generally well tolerated in the study population. ClinicalTrials.gov Identifier: NCT03493542. PMID: 33239228 [PubMed - as supplied by publisher] (Source: Vaccine)
View on the web

No comments:

Post a Comment